zoledronic acid has been researched along with Anemia, Cooley's in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel Rahman, MO; Abdelrazek, MT; Elkourashy, SA; Fadul, AM; Hamad, AA; Hussein, RM; Kassem, NA; Nashwan, AJ; Poil, AR; Yassin, MA | 1 |
| Akbarzadeh, R; Aliasgharian, A; Darvishi-Khezri, H; Fazli, M; Kosaryan, M | 1 |
| Lampropoulou-Adamidou, K; Tournis, S; Triantafyllopoulos, IK | 1 |
| Kulkarni, H; Mamtani, M | 1 |
| Aubry-Rozier, B; Lamy, O; Lucini, M; Stoll, D | 1 |
| Athanassiou-Metaxa, M; Garypidou, V; Harsoulis, F; Perifanis, V; Tziomalos, K; Vakalopoulou, S; Vyzantiadis, T | 1 |
| Mahachoklertwattana, P | 1 |
| Anagnostopoulos, A; Kiamouris, C; Konstantopoulos, K; Spyropoulou, E; Stoupa, E; Terpos, E; Voskaridou, E | 1 |
| Bowden, DK; Crawford, BA; Gilfillan, CP; Kean, AM; Obaid, M; Rodda, CP; Strauss, BJ | 1 |
| Athanassiou-Metaxa, M; Garipidou, V; Harsoulis, F; Perifanis, V; Tziomalos, K; Vakalopoulou, S; Vyzantiadis, T | 1 |
| Gogia, N; Kumar, R; Mahapatra, M; Malik, M; Pillai, LS; Puri, T; Sharma, DN | 1 |
2 review(s) available for zoledronic acid and Anemia, Cooley's
| Article | Year |
|---|---|
Atypical femoral fracture in a beta-thalassemia major patient with previous bisphosphonate use: case report and a review of the literature.
Topics: Adult; beta-Thalassemia; Bone Density Conservation Agents; Diphosphonates; Femoral Fractures; Humans; Imidazoles; Male; Osteoporosis; Zoledronic Acid | 2016 |
Bone recovery after zoledronate therapy in thalassemia-induced osteoporosis: a meta-analysis and systematic review.
Topics: Adolescent; Adult; beta-Thalassemia; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Randomized Controlled Trials as Topic; Young Adult; Zoledronic Acid | 2010 |
4 trial(s) available for zoledronic acid and Anemia, Cooley's
| Article | Year |
|---|---|
Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis.
Topics: beta-Thalassemia; Bone Density Conservation Agents; Clinical Trials, Phase III as Topic; Denosumab; Humans; Osteoporosis; Randomized Controlled Trials as Topic; Zoledronic Acid | 2020 |
Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial.
Topics: beta-Thalassemia; Bone Density; Bone Resorption; Diphosphonates; Humans; Imidazoles; Osteoporosis; Placebos; Treatment Outcome; Zoledronic Acid | 2006 |
A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in the treatment of thalassemia-associated osteopenia.
Topics: Adolescent; Adult; Alkaline Phosphatase; beta-Thalassemia; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Male; Zoledronic Acid | 2006 |
Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
Topics: Adult; beta-Thalassemia; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Collagen Type I; Diphosphonates; Female; Humans; Imidazoles; Insulin-Like Growth Factor I; Male; Osteocalcin; Osteoporosis; Osteoprotegerin; Peptides; Treatment Outcome; Zoledronic Acid | 2007 |
5 other study(ies) available for zoledronic acid and Anemia, Cooley's
| Article | Year |
|---|---|
Administration of Intravenous Zoledronic Acid Every 3 Months vs. Annually in β-thalassemia Patients with Low Bone Mineral Density: a Retrospective Comparison of Efficacy.
Topics: Absorptiometry, Photon; Adult; beta-Thalassemia; Bone Density; Bone Density Conservation Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Femur Neck; Humans; Iran; Lumbar Vertebrae; Male; Osteoporosis; Retrospective Studies; Treatment Outcome; Zoledronic Acid | 2018 |
[Should we treat thalassemia-induced osteoporosis: two case reports].
Topics: Absorptiometry, Photon; Adult; Antibodies, Monoclonal, Humanized; beta-Thalassemia; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Humans; Hypogonadism; Imidazoles; Infusions, Intravenous; Male; Osteoporosis; Zoledronic Acid | 2012 |
Treatment of beta-thalassaemia-associated osteoporosis with zoledronic acid.
Topics: Adult; beta-Thalassemia; Diphosphonates; Female; Humans; Imidazoles; Insulin-Like Growth Factor I; Male; Osteoporosis; Zoledronic Acid | 2004 |
Zoledronic acid for the treatment of thalassemia-induced osteonecrosis.
Topics: beta-Thalassemia; Diphosphonates; Dose-Response Relationship, Drug; Humans; Imidazoles; Osteonecrosis; Osteoporosis; Zoledronic Acid | 2006 |
Paraplegia due to extramedullary hematopoiesis in thalassemia treated successfully with radiation therapy.
Topics: Adult; beta-Thalassemia; Blood Transfusion; Calcium; Cobalt Radioisotopes; Contraindications; Decompression, Surgical; Diphosphonates; Epidural Space; Folic Acid; Fractures, Spontaneous; Hematopoiesis, Extramedullary; Humans; Imidazoles; Male; Osteoporosis; Paraplegia; Radioisotope Teletherapy; Spinal Cord Compression; Zoledronic Acid | 2007 |